German Spondyloarthritis Inception Cohort (GESPIC)
The German Spondyloarthritis Inception cohort (GESPIC) was started as a prospective, longitudinal, multicentre, nationwide study in Germany on patients with early SpA including ankylosing spondylitis and non-radiographic axial. The objectives of GESPIC are to learn about the course of AS and other SpA during the very early stage of the disease, to appropriately assess the outcome including radiographic progression of patients after several years of follow-up, to identify outcome predictors, to assess quality of life, function, and costs (direct and indirect costs).
Non-radiographic Axial Spondyloarthritis
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||German Spondyloarthritis Inception Cohort|
|Study Start Date:||July 2000|
|Estimated Primary Completion Date:||July 2018 (Final data collection date for primary outcome measure)|
Ankylosing spondylitis according to the modified New York criteria and duration of symptoms <10 years
Non-radiographic axial spondyloarthritis
Patients with clinical characteristics of axial SpA but not fulfilling the modified New York criteria for which radiographic sacroiliitis is essential. Maximal duration of symptoms: 5 years.
Patients with juvenile spondyloarthritis (juvenile ankylosing spondylitis, juvenile non-AS-spondyloarthritis).
Please refer to this study by its ClinicalTrials.gov identifier: NCT01277419
|Charité Universitätsmedizin Berlin|
|Principal Investigator:||Joachim Sieper, Prof. Dr.||Charite University, Berlin, Germany|
|Study Chair:||Martin Rudwaleit, PD Dr.||Charite University, Berlin, Germany|